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ABSTRACT
This study has estimated the risk of Leishmania transmission via blood transfusion in one 
of the largest blood banks in Northeastern Brazil, where visceral leishmaniasis is endemic. 
Five hundred blood samples from donors were tested for circulating Leishmania spp. DNA 
by real-time PCR. Positive samples were tested by a species-specific conventional PCR 
targeting Leishmania infantum. Overall, 6.2% (95% CI: 4.1–8.3%) of the samples carried 
Leishmania DNA and in one sample the species was confirmed as L. infantum. No statistically 
significant differences were found in relation to gender, sex, education level, incomeas well 
as the place of residence between positive and negative blood donors. Our results confirm 
the presence of asymptomatic Leishmania carriers among blood donors in a large blood bank 
in Northeastern Brazil. Considering the studied population, we estimate that for every 1,000 
blood donors screened, 41 to 83 will be positive for Leishmania DNA. This finding reinforces 
the urgent need for elaborating specific Blood bank guidelines to allow the early detection 
of asymptomatic Leishmania carriers among blood donors before their blood products are 
transfused to uninfected individuals.
KEYWORDS: Blood donors. Leishmania. Asymptomatic infection. Blood bank. 
Surveillance.
INTRODUCTION
Visceral leishmaniasis (VL) is a severe neglected disease caused by protozoa 
belonging to the Leishmania donovani species complex, which affects approximately 
200,000 to 400,000 people annually, with most of the cases being reported in Brazil, 
India, Sudan, South Sudan, Ethiopia and Bangladesh1. The clinical manifestations of 
VL are directly related to the patient’s immune response and also to virulence factors 
of the infecting Leishmania species2. Hence, even though many infected people 
remain asymptomatic, the disease is often severe and potentially fatal3,4. Indeed, it 
is estimated that 20,000 to 40,000 people die from VL every year in endemic areas1.
In the Mediterranean Basin, Middle East, Central Asia, South America and 
Central America, VL is a zoonosis caused by Leishmania infantum5. Although 
primarily transmitted by female phlebotomine sand flies6, L. infantum may also 
be transmitted by other routes, including blood transfusion7. Cases of transfusion-
transmitted leishmaniasis have been reported in several countries such as Belgium, 
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France, Brazil, Sweden and the United Kingdom7. In spite 
of that, blood donors’ screening for L. infantum infection 
is not routinely performed in several endemic countries7,8, 
including Brazil9. Although the risk of L. infantum 
transmission via blood transfusion is eminent, it remains 
largely underestimated in most countries. A screening in 
blood banks of different Brazilian cities (Montes Claros, 
Fortaleza, and Teresina) reported that among 615 clinically 
eligible donors, seven (1.1%) were positive in the screening 
procedure, a rapid immunochromatographic test10. 
Considering the total of 608 eligible donors, 37 (6.1%) 
were positive to Leshmania spp. by a commercial ELISA. 
Furthermore, among 296 patients who were transfused 
with red blood cells or platelet concentrates from the 
above-mentioned donors, 23 (7.8%) were seropositive 
prior to blood transfusion and 13 (4.4%) received blood 
from positive donors. Six patients were followed-up and 
two of these six seroconverted between 60 and 90 days 
after blood transfusion10. This study illustrates the tip of 
the iceberg regarding L. infantum transmission by blood 
donors in Brazil.
Evidence accumulated in recent decades indicates 
that many individuals infected with Leishmania living in 
endemic areas may remain asymptomatic and become blood 
donors. Nonetheless, the risk of Leishmania transmission 
via blood transfusion remains largely underestimated. In 
this context, the aim of the present study was to estimate 
the risk of Leishmania transmission via blood transfusion 
in one of the largest blood banks in Northeastern Brazil, 
where VL is endemic.
METHODS
Study population
This cross-sectional study was carried out in the 
Fundacao de Hematologia e Hemoterapia de Pernambuco 
(Hemope), from August to September of 2017 (Figure 1). 
Before blood collection, blood donors were invited to 
participate in the study. After signing the informed consent, 
blood donors answered a questionnaire regarding age, 
schooling, income and place of residence. Routinely, all 
Figure 1 - Location of the Fundacao de Hematologia e Hemoterapia de Pernambuco (Hemope) and the geographic regions of 
Pernambuco State, from where blood donors came from. Numbers and percentages (in parentheses) refer to the number of positive 
patients and the positivity in each region. The maps were produced using the QGIS software version 2.18.28 (Free Software 
Foundation, Boston, Massachusetts, USA) and based on public geographical data obtained from OpenStreetMaps30.
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blood donors are subjected to a clinical screening (i.e., 
heart rate, blood pressure, temperature, weight, height, 
hemoglobin and hematocrit levels) and only those classified 
as clinically healthy (asymptomatic) are considered eligible 
for donation. In this blood bank, blood samples from donors 
are also routinely screened for syphilis, Chagas disease, 
hepatitis B and C, human immunodeficiency virus (HIV), 
human T-lymphotropic virus (HTLV) I and II, in addition 
to blood typing and Rh factor.
This study was approved by the ethics and research 
committees of the Aggeu Magalhaes Institute (Fiocruz-PE) 
(CAEE Nº 65770317.9.0000.5190) and the Hematology 
and Hemotherapy Foundation of Pernambuco (Hemope). 
All subjects were adults and voluntarily signed an informed 
consent before their enrolment in the study. All procedures 
were carried out in accordance with relevant guidelines 
and regulations.
Sampling
Venous blood samples (approximately 4 mL) were 
withdrawn from 500 blood donors and immediately placed 
into EDTA tubes (BD Vacutainer, Becton Dickinson, 
Franklin Lakes, NJ, USA), which were previously labelled 
with a unique bar code for each donor. Then, 600 μL 
aliquots were transferred to a 1.5 mL microtube (Eppendorf, 
Hamburg, Germany) and frozen at –80 °C until further 
analysis.
Molecular diagnosis
Extraction of genomic DNA from blood samples and 
from cultured Leishmania promastigotes [reference strains: 
L. infantum (MHOM/BR/2016/DBA) and Leishmania 
braziliensis (MHOM/BR/2016/FAL)] were performed 
using the Wizard Genomic DNA Purification kit (Promega 
Corporation, Madison, WI, USA) according to the 
manufacturer’s instructions. The quality of the extracted DNA 
was assessed using a NanoDrop-2000C spectrophotometer 
(Thermo Scientific, Waltham, MA, USA).
DNA samples were screened for the presence of 
Leishmania  spp.  kinetoplas t  DNA by a  real -
time PCR (qPCR), using the primers LEISH-1 
(5’-AACTTTTCTGGTCCTCCGG GTAG-3’) and LEISH-2 
(5’-ACCCCCAGTTTCCCGCC-3’), and the TaqMan-MGB 
probe (FAM-5’-AAAAATGGGTGCAGAAAT-3’-non-
fluorescent quencher-MGB), as described elsewhere11. 
This assay detects different Leishmania spp., not only 
L. infantum12. The reaction mixture contained 7.5 μL of 
TaqMan Genotyping master mix (2X), 1.35 μL of each 
primer (final concentration of 900 nM each), 0.3 μL of probe 
(final concentration of 200 nM each), 2.5 μL of sterile 
water (DNase and RNase free) and 2.0 μL of genomic 
DNA, in a final volume of 15 μL. The thermal cycling 
conditions (QuantStudio 5 Real-Time PCR machine, Applied 
Biosystems, Foster City, CA, USA) were set as follow: 50 °C 
for 2 min, 95 °C for 10 min, 40 cycles of 95 °C for 15 s, and 
60 °C for 1 min. Samples were initially screened one by 
one and them positive samples were rested in duplicate. A 
standard curve with six serial dilutions (100 pg, 10 pg, 1 pg, 
100 fg, 10 fg, and 1 fg per reaction) of genomic DNA from 
L. infantum was used as positive controls and also to estimate 
the parasite load in blood samples. DNA-free water was used 
as non-template control (NTC).
Positive samples by qPCR were further tested by a 
species-specific conventional PCR assay, using the primers 
FLC2 (5’-GTCAGTGTCGGAAACTAATCC GC-3’) 
and RLC2 (5’-GGGAAATTGGCCTCCCTGAG-3’), 
which amplify a 230 bp fragment of L. infantum kDNA13. 
The final reaction volume was 25 μL, consisting of 1 X 
buffer, 0.2 mM dNTP (dATP, dCTP, dGTP, and dTTP), 
1.5 mM MgCl
2
, 1.5 U Taq Polymerase (Invitrogen,Thermo 
Scientific, Waltham, MA, USA), 0.4 pmol of each primer 
and 2 μL of genomic DNA. Genomic DNA from L. infantum 
and L. braziliensis were used as positive and negative 
controls, respectively. PCR assays were carried out in 
a LifeECO Thermal Clycler Bioer (Bioer Technology, 
Hangzhou, China), using the following thermal cycling 
conditions: initial denaturation at 95 °C for 10 min, followed 
by 35 cycles of 94 °C for 1 min, 56 °C for 1 min and 72 °C 
for 30 s, and a final extension at 72 °C for 10 min. PCR 
products were subjected to 1% agarose gel electrophoresis 
with 1 X tris-borate-EDTA buffer (pH 8.0) at 150 V and 
400 mA for 1 h and 20 min. Gels were stained with ethidium 
bromide (0.5 μg/mL) and visualized under ultraviolet light.
Statistical analyses
The minimum sample size (n = 377) was calculated 
considering a 5% margin of error, 95% confidence level, 
unknown population size and expected positivity of 50%, 
using GraphPad Prism software version 5.0 (GraphPad 
Software Inc., San Diego, CA, USA). The positivity rate 
was calculated as the percentage (%) of positive individuals 
among all screened individuals. The 95% confidence 
interval was also calculated. The positivity rate was 
analyzed according to sociodemographic characteristics of 
the study population, using Chi-square (χ2) or G-test (G). 
Differences were considered statistically significant when 
the P value was equal or less than 5. Statistical analyses 
were conducted using the BioEstat software, version 5.3 
(Mamirauá Institute, Tefé, Amazonas, Brazil).
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RESULTS
Among the total of 500 blood donors enrolled in this 
study, 42.6% (n = 213) were female and 57.4% (n = 287) 
male (Table 1). Regarding the skin color, 35.0% (175) were 
of mixed ethnicity, 30.4% (n = 152) white, 25.4% (n = 127) 
black, with other self-declared skin colors accounting for the 
remaining 9.2% (n = 46). Regarding age, 50.2% (n = 251) 
of the donors were 18-25 years old, 27.4% (n = 137) 
26-33 years old, 12.2% (n = 61) 34–41 years old, 8.2% 
(n = 41) 42–50 years old and 2.0% (n = 10) 51–60 years old. 
The age groups 18–25 and 26–33 years old corresponded to 
77.6% of the total. In respect to the education level, most 
donors had completed superior education (n = 479; 95.8%), 
with 4.2% (n = 21) of the donors presenting with only the 
elementary education.
Analyzing the place of residence, 437 (87.4%) resided in 
the metropolitan region of Recife, 49 (9.8%) in the Atlantic 









Female 199 (93.4) 14 (6.6) χ2 = 0.06, df = 1, P = 0.812
Male 270 (94.1) 17 (6.0)
Skin color
White 142 (93.4) 10 (6.6) G = 2.41, df = 4, P = 0.661
Black 117 (92.1) 10 (7.9)
Yellow 44 (97.8) 1 (2.2)
Mixed Ethnicity 165 (94.3) 10 (5.7)
Indigenous 1 (100.0) 0 (0.0)
Age (years)
18-25 234 (93.2) 17 (6.8) G = 2.60, df = 4, P = 0.626
26-33 128 (93.4) 9 (6.6)
34-41 59 (96.7) 2 (3.3)
42-50 38 (92.7) 3 (7.3)
51-60 10 (100.0) 0 (0.0)
Schooling
1-5 years 5 (100.0) 0 (0.0) G = 6.49, df = 3, P = 0.090
6-9 years 16 (100.0) 0 (0.0)
High school 239 (95.6) 11 (4.4)
Higher education 209 (91.3) 20 (8.7)
Income*
< 1 minimum wage 6 (100.0) 0 (0.0) G = 3.43, df = 4, P = 0.488
1-2 minimum wages 251 (94.0) 16 (6.0)
3-4 minimum wages 127 (91.4) 12 (8.6)
5-6 minimum wages 48 (96.0) 2 (4.0)
>7 minimum wages 35 (97.2) 1 (2.8)
Place of residence
Metropolitan region of Recife 408 (93.4) 29 (6.6) G = 2.36, df = 4, P = 0.670
Atlantic rainforest 47 (95.9) 2 (4.1)
Agreste region 11 (100.0) 0 (0.0)
Semi-arid region 2 (100.0) 0 (0.0)
Other State 1 (100.0) 0 (0.0)
*In the income variable, two participants did not respond. G-test = G; degrees of freedom = df
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rainforest region, 11 (2.2%) in the agreste region, two 
(0.4%) in the semi-arid region, one (0.2%) in another state. 
When asked about the water supply, 99.6% (498) of the 
donors reported access to potable water. Regarding the type 
of sewage system, 87.2% (n = 436) reported having access 
to basic sanitation, 5.2% (n = 26) had no access and 7.6% 
(n = 38) did not know.
Upon qPCR testing, 31 out of 500 (6.2%; 95% CI: 
4.1-8.3%) blood samples were found to carry Leishmania 
DNA. Most positive donors were males and individuals 
with age ranging from 18 to 25 years (Table 1). Almost 
all Leishmania-positive donors were residents of the 
Metropolitan region of Recife (n = 29), with only two 
donors coming from the agreste region. The parasite 
load ranged from 2.2 to 201.0 parasites per mL of blood 
(average, 31.6 parasites/mL). Only two positive blood 
donors presented with more than 100 parasites per mL of 
blood (Figure 2).
When qPCR-positive samples were tested by the 
conventional PCR targeting L. infantum DNA, only one 
was positive. 
DISCUSSION
In this study, we investigated the presence of Leishmania 
DNA in blood samples from donors coming spontaneously to 
a large blood bank in Northeastern Brazil. We found that 6.2% 
of the donors were carrying Leishmania DNA in their blood, 
and all of them were asymptomatic. Although the majority 
of positive blood donors resided in municipalities belonging 
to the Metropolitan region of Recife, the possibility that the 
infection had been acquired elsewhere cannot be ruled out.
Similar studies reporting the presence of anti-Leishmania 
antibodies or Leishmania DNA in asymptomatic blood 
donors have been carried out in Brazil10,14-21. Altogether, our 
results confirm that asymptomatic Leishmania infections are 
relatively frequent among blood donors living in endemic 
areas, since the screening of Leishmania DNA in blood 
banks in Brazil is still not routinely performed.
Different methods have been tested to prevent 
contamination of blood bags or even to destroy Leishmania 
parasites present in contaminated blood bags. For instance, 
filtration systems can remove several pathogens (e.g., 
cytomegalovirus, human T-lymphotropic virus, Orientia 
tsutsugamushi and Trypanosoma cruzi) from blood 
components22. Leukodepletion filters used at the time of 
blood collection or bedside filters used after storage are 
reputed to be the best strategies to minimize the risk of blood 
transfusion transmission of Leishmania parasites7,22,23. 
The only issue related to the use of leukodepletion filters 
is the high costs, which may limit their large-scale use, 
particularly in low-income countries.
It is acknowledged that diagnosing asymptomatic 
Leishmania infections is not an easy task, due to the low 
parasite load and low to moderate humoral response in 
healthy, infected individuals8. In fact, we found a low parasite 
load among positive blood donors (mean of 31.6 parasites per 
mL of blood), highlighting the need of highly sensitive assays 
(e.g., qPCR) for detecting Leishmania infections in healthy 
individuals, as it is the case of blood donors. As a corollary, 
only one blood donor, with a parasite load of 201,01 parasites/
mL of blood, was positive when tested by conventional PCR, 
reinforcing the superiority of qPCR for detecting Leishmania 
DNA in asymptomatic carriers, especially when using blood 
samples, usually containing less parasite DNA as compared 
to other samples, such as bone marrow. Furthermore, the 
qPCR assay used herein is not specific for L. infantum, as 
it also detects L. braziliensis, another species endemic in 
Pernambuco24. The fact that only one qPCR-positive sample 
was positive in the L. infantum-specific conventional PCR 
could be related to the lower sensitivity of this assay or even 
to the presence of L. braziliensis. In fact, it is known that L. 
braziliensis DNA can be detected in blood samples of animals 
and humans25,26. The possibility that L. braziliensis could be 
transmitted via blood transfusion has been speculated19, but 
remains unproven. 
It has been shown that individuals with higher parasite 
load are more infectious to phlebotomine sand fly vectors27. 
Nonetheless, the fact that blood donors examined herein 
presented a low parasite load and were asymptomatic 
does not necessarily mean that they are not infectious. A 
recent study suggested that not only VL patients, but also 
asymptomatic infected individuals could serve as a source 
of infection to phlebotomine sand fly vectors28.
It is acknowledged that VL is a disease of the poorest of 
the poor. The disease affects disproportionally poor people, 
Figure 2 - Frequency of different parasite load ranges detected 
among the 31 positive blood donors for Leishmania spp. DNA 
detection by quantitative PCR.
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living in rural areas or in suburbs, where the exposure to the 
vectors as well as the existence of predisposing factors (e.g., 
malnutrition and HIV coinfection) is frequent. In this study, 
no statistically significant differences were found in relation 
to gender, skin color, education level, income and place of 
residence. The absence of statistical differences may be partly 
explained by the low number of infected individuals, but may 
also indicates the lack of a well-defined epidemiological 
profile for Leishmania-infected blood donors29.
The determinant factors for progression from 
asymptomatic infection to symptomatic VL in humans 
are still poorly understood, but may be related to genetic 
background, nutritional status, underlying disease and/or 
coinfections. As such, we encourage public health authorities 
to elaborate specific guidelines for diagnosing and managing 
Leishmania infections in asymptomatic carriers in Brazil. 
These guidelines should also deal with blood donors 
diagnosed as infected during routine testing in blood banks, 
as well as blood recipients that received blood from infected 
donors. Finally, blood banks should exclude donors that are 
positive for Leishmania, as emphasized elsewhere22.
In conclusion, we report herein the finding of asymptomatic 
Leishmania carriers in 6.2% of asymptomatic blood donors 
in a large blood bank in Northeastern Brazil. This finding 
reinforces the urgent need for elaborating specific blood 
bank guidelines to allow the early detection of asymptomatic 
Leishmania carriers who show up to donate blood before their 
blood products are transfused to uninfected individuals. This 
would ultimately benefit both, asymptomatic Leishmania 
carriers themselves, but especially blood recipients by 
reducing the risk of VL in these individuals.
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